Neil E Forsberg

US Patent:

7939066, May 10, 2011

Filed:

Jul 13, 2006

Appl. No.:

11/457176

Inventors:

Steven Bruce Puntenney - Independence OR, US
Neil Elliott Forsberg - Corvallis OR, US

Assignee:

OmniGen Research, LLC - Corvallis OR

International Classification:

A61K 38/47
A61K 31/715

US Classification:

424 9461, 514 54, 426656, 426807

Abstract:

A method for the prevention and treatment of fungal infections and, therefore, consequent invasive mycosis in mammalian and avian species is described. The invention comprises a combination of β-1,3(4)-endoglucanohydrolase, β-1,3(4)glucan, diatomaceous earth, mineral clay, and glucomannan, which is fed to or consumed by mammalian or avian species in amounts sufficient to inhibit enteric fungal colonization in the gut and consequent mycosis. The invention described may be admixed with feeds or foods, incorporated into pelleted feeds or foods or administered orally to mammalian and avian species.

US Patent:

8142798, Mar 27, 2012

Filed:

Apr 26, 2006

Appl. No.:

11/380359

Inventors:

Neil E. Forsberg - Corvallis OR, US
Steven B. Puntenney - Independence OR, US

Assignee:

OmniGen Research, L.L.C. - Corvallis OR

International Classification:

A61K 45/00
A61K 39/00
A01N 63/00

US Classification:

4242781, 424 931, 4242821

Abstract:

The disclosure relates to a composition added to animal feed used in combination with a vaccine to enhance the effectiveness of the vaccine. Amongst other effects, the composition raises the titer of antibodies to the vaccine.

US Patent:

8236303, Aug 7, 2012

Filed:

Jan 29, 2007

Appl. No.:

11/668375

Inventors:

Neil E. Forsberg - Corvallis OR, US
Steven B. Puntenney - Independence OR, US

Assignee:

OmniGen Research, LLC - Corvallis OR

International Classification:

A61K 38/47

US Classification:

424 9461, 514 54, 426 2, 426656

Abstract:

A method for the augmentation of immune function is described. The invention comprises a combination of β-1,3(4)-endoglucanohydrolase, β-1,3(4)glucan, diatomaceous earth, mineral clay and glucomannan, which is fed to or consumed by mammalian or avian species in amounts sufficient to augment immune function. The invention described may be admixed with feeds or foods, incorporated into pelleted feeds or foods or administered orally to mammalian and avian species.

US Patent:

8431133, Apr 30, 2013

Filed:

Feb 20, 2012

Appl. No.:

13/400520

Inventors:

Neil Elliott Forsberg - Corvallis OR, US
Steven Bruce Puntenney - Canby OR, US

Assignee:

OmniGen Research, L.L.C. - Corvallis OR

International Classification:

A61K 39/00
A61K 39/02
A61K 39/385

US Classification:

4241841, 4241931, 42419711, 4242341

Abstract:

The disclosure relates to a composition added to animal feed used in combination with a vaccine to enhance the effectiveness of the vaccine. Amongst other effects, the composition raises the titer of antibodies to the vaccine.

US Patent:

8568715, Oct 29, 2013

Filed:

Aug 3, 2012

Appl. No.:

13/566433

Inventors:

Steven B. Puntenney - Ione OR, US
Neil E. Forsberg - Corvallis OR, US

Assignee:

OmniGen Research, L.L.C. - Corvallis OR

International Classification:

A61K 38/47

US Classification:

424 9461, 514 54, 426 2, 426656, 426807

Abstract:

A method for the augmentation of immune function is described. The invention comprises a combination of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan, which is fed to or consumed by mammalian or avian species in amounts sufficient to augment immune function. The invention described may be admixed with feeds or foods, incorporated into pelleted feeds or foods or administered orally to mammalian and avian species.

US Patent:

20050180964, Aug 18, 2005

Filed:

Mar 17, 2003

Appl. No.:

10/388525

Inventors:

Steven Puntenney - Canby OR, US
Neil Forsberg - Corvallis OR, US

International Classification:

A61K038/47
A61K031/715

US Classification:

424094610, 514054000

Abstract:

A method for the prevention and treatment of fungal infections and, therefore, consequent invasive mycosis in mammalian and avian species is described. The invention comprises a combination of β-1,3(4)-endoglucanohydrolase, β-1,3(4)glucan, diatornaceous earth, mineral clay, and glucomannan, which is fed to or consumed by mammalian or avian species in amounts sufficient to inhibit enteric fungal colonization in the gut and consequent mycosis. The invention described may be admixed with feeds or foods, incorporated into pelleted feeds or foods or administered orally to mammalian and avian species.

US Patent:

20050220846, Oct 6, 2005

Filed:

Apr 5, 2004

Appl. No.:

10/829633

Inventors:

Steven Puntenney - Canby OR, US
Neil Forsberg - Corvallis OR, US

International Classification:

A61K038/47
A61K033/06

US Classification:

424442000, 424094610, 424684000

Abstract:

A method for the augmentation of immune function is described. The invention comprises a combination of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4)glucan, diatomaceous earth, mineral clay and glucomannan, which is fed to or consumed by mammalian or avian species in amounts sufficient to augment immune function. The invention described may be admixed with feeds or foods, incorporated into pelleted feeds or foods or administered orally to mammalian and avian species.

US Patent:

20050227236, Oct 13, 2005

Filed:

Feb 10, 2004

Appl. No.:

10/776646

Inventors:

Neil Forsberg - Corvallis OR, US
Steven Puntenney - Canby OR, US

International Classification:

C12Q001/68
C12P019/34

US Classification:

435006000, 435091200

Abstract:

Isolated nucleic acids, kits and methods are disclosed for detecting, quantifying and/or identifying a fungal species in a sample or for diagnosing jejunal hemorrhage syndrome in a subject. The methods generally include amplifying a fungal nucleic acid sequence present in the sample using a primer selected from the group consisting of: SEQ. ID NO 5, SEQ. ID NO 6, SEQ. ID NO 7, SEQ. ID NO 8, SEQ. ID NO 9, SEQ. ID NO 10, SEQ. ID NO 11, SEQ. ID NO 12, SEQ. ID NO 13, SEQ. ID NO 14 or SEQ. ID NO 16; and observing or measuring the amplified nucleic acid sequence. The fungal species can thereby be detected, quantified, and/or identified. Fungal contamination also can be detected or measured in a biological or feed or food sample.